A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia - Papanicolaou, D A; Ather, S N; Zhu, H (J Nutr Health Aging, 2013)
et al.